By Overview
Tay-Sachs disease is a rare genetic disorder caused by a gene mutation that affects the nervous system. This mutation leads to the accumulation of a fatty substance called GM2 ganglioside in the brain, which progressively damages nerve cells.
Tay-Sachs disease is most common among people of Ashkenazi Jewish descent, but it can also occur in individuals of French-Canadian, Irish, or Cajun descent.
Symptoms of Tay-Sachs disease usually appear during infancy and may include:
- Muscle weakness
- Loss of motor skills such as crawling or sitting
- Exaggerated startle reaction to sudden noises
As the disease progresses, affected children may experience:
- Loss of vision and hearing
- Seizures
- Intellectual disabilities
- Paralysis in advanced stages
Unfortunately, Tay-Sachs disease is fatal, with most affected children not surviving beyond early childhood. There is currently no cure, and treatment focuses on managing symptoms and providing supportive care.
However, genetic testing can help identify carriers of the mutated gene. This preventive measure is essential for those at risk, allowing individuals to make informed reproductive choices and reduce the likelihood of passing the disease to future generations.
